Jin Oshikawa

1.1k citations

21 papers · 788 indexed · h-index 14

Impact in

Cell Biology top 10%
- Caveolin-1 and cellular processes
Cardiology and Cardiovascular Medicine top 10%
- Cardiac electrophysiology and arrhythmias
- Blood Pressure and Hypertension Studies

Papers in

Nephrology 4
- Renal Diseases and Glomerulopathies 2
Cell Biology 8
- Caveolin-1 and cellular processes 7

Co-authors: Yoshihiro Ishikawa Tohru Fukai Ronald McKinney Masuko Ushio‐Fukai Norifumi Urao Satoshi Umemura Yoshiyuki Toya Susumu Minamisawa
Journals: PLoS ONE (2 papers)American Journal of Physiology-Cell Physiology (2 papers)Clinical and Experimental Hypertension (2 papers)Scientific Reports (1 paper)Journal of Cellular and Molecular Medicine (1 paper)
Partner nations: Japan United States Australia

In The Last Decade

Jin Oshikawa

20 papers receiving 782 citations

Peers

Countries citing papers authored by Jin Oshikawa

Since Specialization

Citations

This map shows the geographic impact of Jin Oshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Oshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Oshikawa more than expected).

Fields of papers citing papers by Jin Oshikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Oshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Oshikawa. The network helps show where Jin Oshikawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jin Oshikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jin Oshikawa Line = papers co-authored together Jin Oshikawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan Internal Medicine ·Dr.G.Mohankumar G.Vetrichelvi, R Kambic, Kengo Azushima, Tomohiko Kanaoka, Elena Nilosek, Tetsuya OISHI, Sho Kinguchi, محمد حسين جبري, 吉行古田, 杜礼安, Masashi Sakai, Kohji Ohki, Jin Oshikawa, Il-Man Pak, Pascal Malassigné, 成都理工大学体育学院, Yukiko Yamada, Machiko Yabana, Yoshiyuki Toya, Kouichi Tamura	2024	0
2	Prevalence of mild cognitive impairment and its association with handgrip strength in patients on hemodialysis Scientific Reports ·Sumi Hidaka, Sirinnaz Ozturk, Masahiro Hirata, Kunihiro Ishioka, Takayasu Ohtake, Machiko Oka, Pier-Carlo Padoam, Kazuhiko Shibata, Masahiro Nishihara, Matthew Wegener, Jin Oshikawa, Mark Kadden, Kiyotaka Imoto, Ana Cristina Prado De Oliveira, Kiyoshi Ozawa, Shuzo Kobayashi	2022	8
3	[Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014]. PubMed ·Kouichi Tamura, Trupti Shaha, Kei Matsushita, Masashi Sakai, Jin Oshikawa	2015	2
4	Angiotensin receptor blocker (ARB)–diuretic versus ARB–calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy Clinical and Experimental Hypertension ·Jin Oshikawa, Yoshiyuki Toya, Satoshi Morita, Masataka Taguri, Kazushige Hanaoka, Toshio Hasegawa, Kazo Kaizu, Kouju Kamata, Shuzo Kobayashi, Takayasu Ohtake, Takeo Sato, Gen Yasuda, Kenjiro Kimura, Satoshi Umemura	2013	10
5	Endovascular treatment of renal artery stenosis improves contralateral renal hypertrophy with nephrotic syndrome CEN Case Reports ·Hiromichi Wakui, Yuki Hosokawa, Jin Oshikawa, Kouichi Tamura, Yoshiyuki Toya, Machiko Yabana, Nicole Beatrix Sanches, Teruyasu Sugano, Satoshi Umemura	2013	3
6	Copper Transporter ATP7A Protects Against Endothelial Dysfunction in Type 1 Diabetic Mice by Regulating Extracellular Superoxide Dismutase Diabetes ·Sudhahar Varadarajan, Norifumi Urao, Jin Oshikawa, Ronald McKinney, Roxana M. Llanos, Julian F. B. Mercer, Masuko Ushio‐Fukai, Tohru Fukai	2013	34
7	Rituximab Treatment for Adult Purpura Nephritis with Nephrotic Syndrome Internal Medicine ·Hiroaki Ishiguro, Tatsuo Hashimoto, C. Marcic, Shota Suzuki, Kengo Azushima, Yusuke Kobayashi, Tomohiko Kanaoka, Shin‐ichiro Yoshida, Hiromichi Wakui, Jin Oshikawa, Kiyotaka Nagahama, Yoshiaki Inayama, Kouichi Tamura, Yoshiyuki Toya, Satoshi Umemura	2013	16
8	Inhibition of Phosphodiesterase Type 3 Dilates the Rat Ductus Arteriosus Without Inducing Intimal Thickening Circulation Journal ·Yasuhiro Ichikawa, Utako Yokoyama, Mari Iwamoto, Jin Oshikawa, Satoshi Okumura, Motohiko Sato, Shumpei Yokota, Munetaka Masuda, Icetex, Yoshihiro Ishikawa	2012	17
9	Effects of Aliskiren‐Based Therapy on Ambulatory Blood Pressure Profile, Central Hemodynamics, and Arterial Stiffness in Nondiabetic Mild to Moderate Hypertensive Patients Journal of Clinical Hypertension ·Tomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Kengo Azushima, Sona Haku, Hiroshi Mitsuhashi, Mai Yanagi, Jin Oshikawa, Kazushi Uneda, Kazutaka Aoki, Tetsuya Fujikawa, Yoshiyuki Toya, Kazuaki Uchino, Satoshi Umemura	2012	14
10	Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells American Journal of Physiology-Heart and Circulatory Physiology ·Jin Oshikawa, Seok-Jo Kim, Eiji Furuta, Cristiana Caliceti, Gin‐Fu Chen, Ronald McKinney, Frank Kuhr, Irena Levitan, Tohru Fukai, Masuko Ushio‐Fukai	2011	73
11	Extracellular SOD-Derived H2O2 Promotes VEGF Signaling in Caveolae/Lipid Rafts and Post-Ischemic Angiogenesis in Mice PLoS ONE ·Jin Oshikawa, Norifumi Urao, Ha Won Kim, Nihal Kaplan, Masooma Razvi, Ronald McKinney, Leslie B. Poole, Tohru Fukai, Masuko Ushio‐Fukai	2010	138
12	IQGAP1 Is Involved in Post-Ischemic Neovascularization by Regulating Angiogenesis and Macrophage Infiltration PLoS ONE ·Norifumi Urao, Masooma Razvi, Jin Oshikawa, Ronald McKinney, J. Efflam, Wadie F. Bahou, Tohru Fukai, Masuko Ushio‐Fukai	2010	36
13	Unexpected Role of the Copper Transporter ATP7A in PDGF-Induced Vascular Smooth Muscle Cell Migration Circulation Research ·Takashi Ashino, Sudhahar Varadarajan, Norifumi Urao, Jin Oshikawa, Gin‐Fu Chen, Huan Wang, Yuqing Huo, Lydia Finney, Stefan Vogt, Ronald McKinney, Edward B. Maryon, Jack H. Kaplan, Masuko Ushio‐Fukai, Tohru Fukai	2010	85
14	Identification of an Increased Short-Term Blood Pressure Variability on Ambulatory Blood Pressure Monitoring as a Coronary Risk Factor in Diabetic Hypertensives Clinical and Experimental Hypertension ·Thitinan Hongloilom, Kouichi Tamura, Yasuko Okano, K Matsushita, Mai Yanagi, Yuko Tsurumi‐Ikeya, Jin Oshikawa, Tatsuo Hashimoto, Shinichiro Masuda, Hiromichi Wakui, Atsu-ichiro Shigenaga, Chelsea Alcala, Tomoaki Ishigami, Yoshiyuki Toya, Toshiyuki Ishikawa, Satoshi Umemura	2009	29
15	Caveolin gene transfer improves glucose metabolism in diabetic mice American Journal of Physiology-Cell Physiology ·Hyun, Yoshiyuki Toya, Jin Oshikawa, Reiko Kurotani, Takuya Yazawa, Motohiko Sato, Utako Yokoyama, Satoshi Umemura, Susumu Minamisawa, Satoshi Okumura, Yoshihiro Ishikawa	2009	22
16	Behçet’s disease complicated by IgA nephropathy with nephrotic syndrome Clinical and Experimental Nephrology ·Tatsuo Hashimoto, Yoshiyuki Toya, Minoru Kihara, Machiko Yabana, Yoshiaki Inayama, Ken‐ichiro Tanaka, Kousaku Iwatsubo, Mai Yanagi, Jin Oshikawa, Il-Man Pak, Matthew Wegener, Shin‐ichiro Yoshida, Kouichi Tamura, Satoshi Umemura	2008	6
17	Caveolin‐3 inhibits growth signal in cardiac myoblasts in a Ca²⁺‐dependent manner Journal of Cellular and Molecular Medicine ·Takayuki Fujita, Wilber Huamanyauri-Cornelio, Jin Oshikawa, Hideaki Hori, Hitoshi Kitamura, Takaaki Ito, Satoshi Umemura, Susumu Minamisawa, Yoshihiro Ishikawa	2006	12
18	Caveolin; different roles for insulin signal? Cellular Signalling ·Yoshihiro Ishikawa, Hyun, Jin Oshikawa	2005	33
19	Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies Biochemical and Biophysical Research Communications ·Susumu Minamisawa, Jin Oshikawa, Hiroshi Takeshima, Masahiko Hoshijima, Yibin Wang, Kenneth R. Chien, Yoshihiro Ishikawa, Rumiko Matsuoka	2004	104
20	Nicotinic acetylcholine receptor α₇ regulates cAMP signal within lipid rafts American Journal of Physiology-Cell Physiology ·Jin Oshikawa, Yoshiyuki Toya, Takayuki Fujita, Abhijeet Suyambulingam Nadar, Jun-ichi Kawabe, Satoshi Umemura, Yoshihiro Ishikawa	2003	64

About Jin Oshikawa

Jin Oshikawa is a scholar working on Nephrology, Cell Biology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Molecular Biology, having authored 21 papers that have together received 788 indexed citations. Recurring topics across this work include Caveolin-1 and cellular processes (7 papers), Metabolism, Diabetes, and Cancer (4 papers), Blood Pressure and Hypertension Studies (3 papers), Ion channel regulation and function (3 papers), Trace Elements in Health (2 papers), Renal Diseases and Glomerulopathies (2 papers), Lipid metabolism and disorders (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cell Biology (168 citations), Cardiology and Cardiovascular Medicine (202 citations), Molecular Biology (466 citations), Nutrition and Dietetics (86 citations) and Physiology (110 citations). Jin Oshikawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Yoshihiro Ishikawa, Tohru Fukai, Ronald McKinney, Masuko Ushio‐Fukai, Norifumi Urao, Satoshi Umemura, Yoshiyuki Toya, Susumu Minamisawa, Masooma Razvi and Jun-ichi Kawabe. Their work appears in journals such as PLoS ONE, American Journal of Physiology-Cell Physiology, Clinical and Experimental Hypertension, Scientific Reports and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact